ALS drug effectively treats Alzheimer’s disease in new animal study

ALS drug effectively treats Alzheimer’s disease in new animal study

Source: Northwestern Now News

Experimental drug NU-9 — a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) — improves neuron health in animal models of Alzheimer’s disease, according to a new Northwestern University study.

Media Information Release Date: April 8, 2025 Media Contacts Amanda Morris (847) 467-6790
Email Amanda Journal: Proceedings of the National Academy of Sciences Published Paper
NU-9 is a small molecule compound approved for clinical trials by the FDA … [7602 chars]

Read more